| Financial Year |
March 31 2023 |
| Monetary Funds |
207,860,229.62 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
151,109,129.40 |
| Advances to Suppliers |
2,494,404.76 |
| Other Receivables |
4,736,544.05 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
105,448,505.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
885,341.03 |
| Total Current Assets |
475,812,454.32 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
9,799,894.13 |
| Fixed Assetes |
27,923,192.92 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,824,280.52 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
11,698,513.32 |
| Other Non-Current Assets |
5,730,917.45 |
| Sub-Total of Non-Current Assets |
56,976,798.34 |
| Total Assets |
532,789,252.66 |
| Short-Term Loans |
2,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
3,038,548.48 |
| Accounts Payable |
105,592,076.85 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
-- |
| Taxes Payable |
849,831.69 |
| Interest Payable |
49,755.53 |
| Dividend Payable |
-- |
| Other payables |
9,341,932.63 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
247,517.53 |
| Sub-Total of Current Liabilities |
177,065,783.92 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
170,350.70 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
3,652,350.70 |
| Total Liabilities |
180,718,134.62 |
| Paid-In Capital(Or Share Stock) |
346,850,017.00 |
| Capital Surplus |
125,008,469.93 |
| Surplus Reserve |
30,224,042.84 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-150,011,411.73 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
352,071,118.04 |
| Owner's Equity（Stockholder's Equity） |
352,071,118.04 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
532,789,252.66 |
